⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorolithium SCHEMBL28172605 | 0.89 | — | — | |
| SCHEMBL30999226 | 0.75 | — | — | |
| SCHEMBL25560432 | 0.75 | — | — | |
| SCHEMBL28158356 | 0.73 | — | — | |
| SCHEMBL22169123 | 0.72 | — | — | |
| SCHEMBL21535426 | 0.72 | — | — | |
| SCHEMBL18351724 | 0.70 | — | — | |
| SCHEMBL27246 | 0.70 | — | — | |
| SCHEMBL31707876 | 0.68 | — | — | |
| SCHEMBL19642720 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101896512-B | Acrylic emulsion pressure sensitive adhesive composition | ASHLAND LICENSING & INTELLECTU | 2013-08-21 | — | — | CN | claimed |
| US-8252425-B2 | Acrylic emulsion pressure sensitive adhesive composition | ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) | 2012-08-28 | — | — | US | claimed |
| CN-101896512-A | Acrylic emulsion pressure sensitive adhesive composition | ASHLAND LICENSING & INTELLECTU | 2010-11-24 | — | — | CN | claimed |
| EP-2222729-A1 | ACRYLIC EMULSION PRESSURE SENSITIVE ADHESIVE COMPOSITION | Ashland Licensing and Intellectual Property LLC (US) | 2010-09-01 | — | — | EP | claimed |
| US-7786259-B2 | Attachment and elaboration strategies for inverse peptide synthesis | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2010-08-31 | — | — | US | claimed |
| WO-2009075801-A1 | ACRYLIC EMULSION PRESSURE SENSITIVE ADHESIVE COMPOSITION | ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) | 2009-06-18 | — | — | WO | claimed |
| US-20090156731-A1 | Acrylic emulsion pressure sensitive adhesive composition | ARKEMA FRANCE (FR) | 2009-06-18 | — | — | US | claimed |
| US-20080039612-A1 | ATTACHMENT AND ELABORATION STRATEGIES FOR INVERSE PEPTIDE SYNTHESIS | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2008-02-14 | — | — | US | claimed |
| US-7244815-B2 | Attachment and elaboration strategies for inverse peptide synthesis | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2007-07-17 | — | — | US | claimed |
| CN-107496902-B | Cyclosporin-like molecules modified at amino acid 1 and 3 | 康卓维尔制药公司 | 2022-01-18 | — | — | CN | disclosed |
| EP-3433234-B1 | ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | MERCK SHARP & DOHME (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3461835-A1 | CYCLOSPORINE ANALOGUE MOLECULES MODIFIED AT AMINO ACID 1 AND 3 | ContraVir Pharmaceuticals, Inc. (US) | 2019-04-03 | — | — | EP | disclosed |
| EP-2651965-B1 | CYCLOSPORINE ANALOGUE MOLECULES MODIFIED AT AMINO ACID 1 AND 3 | CONTRAVIR PHARMACEUTICALS INC (US) | 2018-12-12 | — | — | EP | disclosed |
| WO-2018106928-A1 | TREATMENT AND PREVENTION OF HBV DISEASES BY CYCLOSPORINE ANALOGUE MOLECULES MODIFIED AT AMINO ACIDES 1 AND 3 | CONTRAVIR PHARMACEUTICALS, INC. (US) | 2018-06-14 | — | — | WO | disclosed |
| WO-2009075801-A1 | ACRYLIC EMULSION PRESSURE SENSITIVE ADHESIVE COMPOSITION | ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) | 2009-06-18 | — | — | WO | disclosed |
| US-20090156731-A1 | Acrylic emulsion pressure sensitive adhesive composition | ARKEMA FRANCE (FR) | 2009-06-18 | — | — | US | disclosed |
| CN-101228169-A | Macrocyclic inhibitors of hepatitis c virus | TIBOTEC PHARM LTD (IE) | 2008-07-23 | — | — | CN | disclosed |
| US-20040132967-A1 | Mimetic peptide comprised of terminal amino acid sequences of surfactant protein b (SP-B) and dipalmitoylphosphatidylcholine for use in treatment of respiratory system disorder | WALTHER FRANS J (US) | 2004-07-08 | — | — | US | disclosed |
| US-6660833-B1 | A dimer of a synthetic lung surfactant protein B | HARBOR-UCLA RESEARCH AND EDUCATION INSTITUTE | 2003-12-09 | — | — | US | disclosed |
| EP-0137418-A1 | Process for the production of partially hydrogenated derivatives of 2-nitro-1,1,1-trifluoralkanes | BAYER AG (DE) | 1985-04-17 | — | — | EP | disclosed |